Pune, India -- (SBWIRE) -- 02/13/2018 -- The Global Cancer Tumor Profiling Market accounted to USD 25,318 million in 2016 growing at a CAGR of 18.3% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Cancer is proving the most fatal disease nowadays, therefor profiling cancer is in the great demand. The potential of cancer profiling is extended from common cancers such as lymphoma and breast cancer to molecular profiling of lung cancer, prostate cancer and acute leukemia. Cancer profiling plays vital role in the diagnosis and understanding of the cancer tumors to help physicians to take appropriate therapeutic decisions.

No. of Report Pages: 350

Request Free Sample Report@ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-cancer-tumor-profiling-market

Major Market Drivers and Restraints:


- Technological advancements for identifying the cancer tumors.

- Increasing the cancer incidences.

- Increase in the use of biomarkers in tumor profiling.

- Availability of Funding for Cancer Research

- Increase in demand for next generation sequencing technique in cancer profiling.

- Lack of Skilled Professionals and Infrastructure

- Growth in demand of personalized medicines


Table of Contents

- Introduction

- Market Segmentation

- Market Overview

- Executive Summary

- Premium Insights

- Global Cancer Tumor Profiling Market, By Technology

- Global Cancer Tumor Profiling Market, By Technique

- Global Cancer Tumor Profiling Market, By Application

- Global Cancer Tumor Profiling Market, By Country

- Global Cancer Tumor Profiling Market: Competitive Landscape

- Global Cancer Tumor Profiling Market, Company Profiles

- Illumina, Inc.

- QIAGEN

- Hoffmann-La Roche Ltd

- HTG Molecular Diagnostics, Inc.

- Genomic Health

- Caris Life Sciences

- Helomics Corp.

- Nanostring Technologies, Inc.

- Oxford Gene Technology

- Abbott

- Helomics Corp.

- Genscript

- Ribomed

- Hologic, Inc.

- Boreal Genomics Inc.

- Appendix

- About Data Bridge Market Research


If you have any special requirements, please let us know and we will offer you the report as you want

For Any Query Speak to Expert @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-cancer-tumor-profiling-market

Market Segmentation by Types

By Technology


- Next-Generation Sequencing

- Polymerase Chain Reaction

- Immunohistochemistry

- In Situ Hybridization

- Microarray


By Technique


- Genomics

- Proteomics

- Epigenetics

- Metabolomics


By Application


- Personalized Medicine

- Diagnostics

- Biomarker Discovery

- Prognostics

- Research applications


On the basis of geography, global cancer tumor profiling market report covers data points for 28 countries across multiple geographies such as


- North America & South America

- Europe

- Asia-Pacific

- Middle East & Africa


Access Full Report @ http://databridgemarketresearch.com/reports/global-cancer-tumor-profiling-market/

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Vishal Dixit

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sales@databridgemarketresearch.com

Investor: investors@databridgemarketresearch.com

Visit Blog: http://databridgemarketresearch.com/blog/

Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research